T. Rowe Price Associates’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.14M | Sell |
2,694,202
-205,984
| -7% | -$470K | ﹤0.01% | 1223 |
|
|
2025
Q1 | $4.5M | Sell |
2,900,186
-39,055
| -1% | -$60.5K | ﹤0.01% | 1282 |
|
|
2024
Q4 | $6.91M | Sell |
2,939,241
-902,261
| -23% | -$2.12M | ﹤0.01% | 1200 |
|
|
2024
Q3 | $13.9M | Sell |
3,841,502
-572,585
| -13% | -$2.08M | ﹤0.01% | 1071 |
|
|
2024
Q2 | $15.4M | Sell |
4,414,087
-1,074,899
| -20% | -$3.74M | ﹤0.01% | 1022 |
|
|
2024
Q1 | $35M | Buy |
5,488,986
+2,487,778
| +83% | +$15.9M | ﹤0.01% | 819 |
|
|
2023
Q4 | $19.3M | Buy |
+3,001,208
| New | +$19.3M | ﹤0.01% | 965 |
|
|
2020
Q1 | – | Sell |
-941,500
| Closed | -$12.4M | – | 2512 |
|
|
2019
Q4 | $12.4M | Sell |
941,500
-208,229
| -18% | -$2.75M | ﹤0.01% | 1277 |
|
|
2019
Q3 | $14.3M | Sell |
1,149,729
-30,667
| -3% | -$381K | ﹤0.01% | 1234 |
|
|
2019
Q2 | $19M | Buy |
1,180,396
+645,879
| +121% | +$10.4M | ﹤0.01% | 1188 |
|
|
2019
Q1 | $16.8M | Buy |
534,517
+32,977
| +7% | +$1.04M | ﹤0.01% | 1226 |
|
|
2018
Q4 | $16.5M | Sell |
501,540
-1,221
| -0.2% | -$40.1K | ﹤0.01% | 1201 |
|
|
2018
Q3 | $15.2M | Buy |
502,761
+2,761
| +0.6% | +$83.3K | ﹤0.01% | 1300 |
|
|
2018
Q2 | $13.4M | Buy |
+500,000
| New | +$13.4M | ﹤0.01% | 1292 |
|